Welcome introduction – Florian Scotté (Villejuif)
Opening ceremony – Challenges in Cancer Pathways – Matti Aapro (Genolier)
Prevention and early detection how to improve – Mario Dicato (Luxembourg), Suzette Delaloge (Villejuif), Jean-Baptiste Meric (Bligny), Matthias Löhr (Heidelberg) & Matti Aapro (Genolier)
The care pathway for breast cancer – Frederic Fiteni (Nîmes) & Alessandro Viansone (Villejuif)
Cardio-oncology, Happy new year – Didier Mayeur (Dijon), Ismail Elalamy (Paris), Isabelle Mahé (Paris) & Elvire Mervoyer (Nantes)
Neurology – Emilie Le Rhun (Zurich), Frederic Dhermain (Villejuif) & Antoine Lemaire (Valenciennes)
Lung – David Planchard (Villejuif), David Hui (Houston) & Elie El-Rassy (Villejuif)
Lessons learned from treating patients with cancer during the pandemic and contributions for the future – Camilla Zimmermann (Toronto) & Ashique Ahamed (Manchester)
Early supportive care – Just a word ? – Richard Bermann (Manchester) & Paolo Bossi (Brescia)
MASCC 2024, A taste of France – Mario Di Palma (Neuilly)
The early drugs corner – Christophe Massard (Rennes), Stéphane Champiat (Villejuif), Maria Die Trill (Madrid) & Christina Ruhlmann (Odense)
Digital Health – Mario Di Palma (Villejuif), Andréas Charalambous (Turku), Anna Letsch (Kiel) & Juliette Fanton d’Andon – Nurse practitioner
Young Physician Award Jean Klastersky – Presentation of the top clinical cases
GI Disorders – Richard Gralla (New York), Jeffrey Crawford (Durham), Jørn Herrstedt (København) & Carla Ida Ripamonti (Brescia)
Survivorship – Maryam Lutsberg (New Haven), Matti Aapro (Genolier), Anne Sophie Tuszynski & Stacey Tinianov (Santa Cruz)
Jean Klastersky Award : “And the winner is…”
Cloture ceremony – What are we waiting for in 2024 ? – Florian Scotté (Villejuif)
Florian Scotté (Villejuif)
Meeting Opening – Cancer Care, Go to the future – Maryam Lustberg (USA)
Long Term Safety – Paolo Bossi (Brescia)
Meet the experts Session – Triple Negative : Pathway’s problematics
Barbara Pistilli (Villejuif) – Gilles Freyer (Lyon)
Meet the experts Session – Non iron deficiency anemia in cancer
Mario Dicato (Luxembourg)
Meet the experts Session – Severe diarrhea and targeted therapies : management
Paolo Bossi (Brescia) – Florian Scotté (Villejuif)
New drugs and safety / Tumor localization – Mario Dicato (Luxembourg)
GI Safety – Jeffrey Crawford (USA)
SYMPOSIUM : Immunotherapy treatment challenges in a home care setting – Florian Scotté (Villejuif)
Skin : From innovative therapies to toxicities – Nicolas Meyer (Toulouse)
Digital Health, Next steps – Mario Di Palma (Villejuif)
Young Physician Award Jean Klastersky – Presentation of the top clinical cases – Jean Klastersky (Bruxelles) – Paolo Bossi (Brescia) – Ivan Krakowski (Bordeaux) – Richard Gralla (USA)
Long term safety 2 – Pere Gascon (Barcelona)
Cardio-Oncology : Managing cardiovascular toxicity – Fausto Roila (Perugia)
SYMPOSIUM
Improving the management of Iparps in clinical practice : a French delphi consensus
New Drugs and Safety / Tumor Localization – Matti Aapro (Genolier)
MASCC JASCC 2023 – Florian Scotté (Villejuif)
Survivorship : From patients to caregivers – Matti Aapro (Genolier)
Unscheduled Pathways – Christophe Massard (Villejuif)
CINV Lecture – Richard Gralla (USA)
Lecture : Communication approaches for challenging situations – Judith Nelson (USA)
Young Physician Award Jean Klastersky – The Award Ceremony – Jean Klastersky (Bruxelles) – Paolo Bossi (Brescia) – Ivan Krakowski (Bordeaux) – Richard Gralla (USA)
Conclusion – Florian Scotté (Villejuif)
Jean-Charles Soria (Washington D.C. USA)
Daily drugs; Antibiotics, IPP, Statins, steroids, etc – Denis Moro-Sibilot (Grenoble)
The gut microbiota in the modulation of anticancer drugs efficacy and toxicity : last data – Lisa De Rosa (Villejuif)
The impact of pandemic on Ethics and Cancer Care – Matti Aapro (Switzerland)
The impact on supportive management – Andrew Davies (UK)
Gynecology – Isabelle Ray-Coquard (Lyon)
Haemato-Oncology: Supportive care and Car T-cell therapy – Stéphane Chèze (Caen)
Urology – Yann Vano (Paris)
Definition and guidelines – Maryam Lustberg (USA)
Canto: A new model for research – Ines Vaz Luis (Villejuif)
Patient’s experience and unmet needs – Patient
Digital health for symptom monitoring – Ethan Basch (USA)
Running to daily practice – Fabrice Denis (Le Mans)
A review of digital programs – Paolo Bossi (Brescia)
From hospital to home care and back – Mario Di Palma (Paris)
Ariane Laparra-Ramakichenin (Le Kremlin-Bicêtre)
Raffaele Ratta (Suresnes)
Is cancer a matter of bad luck? – Mario Dicato (Luxembourg)
Different approaches: CINV, best association from acute to breakthrough – Richard Gralla (USA)
Controversies: Febrile Neutropenia, MASCC tool evidence vs ASCO – Jean Klastersky (Brussels), B. L. Rapoport (South Africa)
Young physician award Jean Klastersky – Presentation of the 3 first clinical cases
Young physician award Jean Klastersky – Presentation of the 3 last clinical cases
New drugs expected in the next future (CAR T, bispecific antibodies…) – Christophe Massard (Rennes)
New coming toxicities – Jean-Marie Michot (Villejuif)
Managing the safety – Olivier Lambotte (Le Kremlin-Bicêtre)
How to deal with frailty – Gilles Freyer (Lyon)
Long term toxicity: are they similar with the acute? – Edith Borcoman (Paris)
How to prevent / manage long term toxicity? – Delphine Loirat (Paris)
Monitoring interest – Paolo Bossi (Brescia)
Didier Mayeur (Dijon)
Gilles Freyer (Lyon)
Covid vaccination: The MDAnderson experience – Ishwaria Mohan Subbiah (USA)
Covid vaccine, what else? – Benjamin Wyplosz (Le Kremlin-Bicêtre)
Breast – Joseph Gligorov (Paris)
GI – Jérôme Desrame (Lyon)
Lung – Nicolas Girard (Paris)
Session Q/R
Ismail Elalamy (Paris)
Young physician award Jean Klastersky – Award ceremony
Why to discuss and when – the main sexual complaints – Marion Aupomerol (Villejuif)
How to discuss – Richard Berman (UK)
Let’s talk about sexual minorities: the ASCO survey – Charles Stewart Kamen (USA), Mandi Pratt-Chapman (USA), Shail Maingi (USA)
Session Q/R
Conclusion Day 1 – Florian Scotté (Villejuif)
Conclusion Day 2 – Florian Scotté (Villejuif)
Ouverture du congrès
SESSION LECTURE
Covid-19 et cancer – Matti Aapro
Retour d’expérience Covid-19 à Gustave Roussy : positif et négatif – Fabrice Barlési
Échanges et retours d’expérience – Paolo Bossi, Richard Gralla, Andrew Davies
MASCC et centres d’excellence en soins de support – Andrew Davies, Toshiaki Saeki
La MASCC en 2020-2021 – Andrew Davies
Table ronde centres labellisés MASCC
expériences italienne, anglaise, française & russe – Andrea Antonuzzo, Richard Berman, Florian Scotté, Anton Snegovoy
Conclusion et ouverture MASCC 2022 – Toshiaki Saeki
Problèmes méthodologiques dans la recherche sur les soins de support – Fausto Roila
Cannabinoïdes
Matti Aapro
Micro-trottoir « Le point de vue du patient »
Du récréatif au thérapeutique : les niveaux de preuve – Ivan Krakowski
Le cannabis en cancérologie : des niveaux de preuve aux besoins non-satisfaits – Antonio Vigano
Session Q/R
Synergies des traitements innovants : efficacité versus tolérance
Avec le soutien institutionnel de MSD – Jean-Marie Michot
Anti-TNF + inhibiteurs de checkpoint – Nicolas Noel
Ce qui nous attend demain : CAR-T cells – Jean-Marie Michot
Ce qui nous attend demain : vaccins et immunomodulateurs – Eric Tartour
Toxicités digestives et traitements innovants – Joël Epstein
Diarrhées – Paolo Bossi
Mucites – Joël Epstein
Nausées/vomissements – Richard Gralla
Young physician award Jean Klastersky
Présentation des 3 premiers cas cliniques
Modérateurs : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Young physician award Jean Klastersky
Présentation des 3 derniers cas cliniques
Modérateurs : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Microbiote – Jeffrey Crawford
Microbiote : de quoi parle-t-on ?– Lisa Derosa
Microbiote et efficacité / tolérance des traitements – Carolina Alves-Costa-Silva
Session Q/R
WGA, NGS et prédispositions génétiques aux toxicités – Pere Gascon
Le point de vue de… – Stephen Sonis
Session Q/R
COVID & Actualités autour de la prise en charge des neutropénies fébriles
Symposium proposé par Biogaran – Gilles Freyer, Florian Scotté
Neutropénie fébrile : GCSF et/ou antibio-prophylaxie
Avec le soutien institutionnel de Pfizer – Jean Klastersky
Point de vue de … – Mario Dicato
Point de vue de – Fausto Roila
Douleur – Maria DiPalma
Neuropathie – nouvelles thérapeutiques et standards de traitements – Ivan Krakowski
Neuropathie – nouvelles thérapeutiques – Berit Jordan
Thérapies complémentaires (médecine basée sur les preuves) – Stéphanie Trager
Session Q/R
Post-JEICT : Données récentes sur les anticoagulants dans le cancer – Ismail Elalamy
Young physician award Jean Klastersky
Remise du prix
Modérateurs : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Habilitation physique et cancer – Andreas Charalambous
Pré-habilitation – Nicolas Barizien
Per-habilitation incluant Covid-19 – Thierry Bouillet
Ré-habilitation incluant Covid-19 – Antonio Vigano
Session Q/R
Conclusion
Florian Scotté (Villejuif)
Meeting Opening – Cancer Care, Go to the future – Maryam Lustberg (USA)
Long Term Safety – Paolo Bossi (Brescia)
Florian Scotté (Villejuif)
Meeting Opening – Cancer Care, Go to the future – Maryam Lustberg (USA)
Long Term Safety – Paolo Bossi (Brescia)
NOS
PARTENAIRES
OUR
PARTNERS
